Korean J Med.  2014 Jan;86(1):54-58. 10.3904/kjm.2014.86.1.54.

A Case of Primaquine-Induced Acute Liver Failure

Affiliations
  • 1Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. leighdb@hanmail.net

Abstract

Primaquine was approved for treatment of malaria in 1952 by the United States Food and Drug Administration (FDA). It has remained the only FDA-licensed drug capable of clearing the intra-hepatic schizonts and hypnozoites of Plasmodium vivax. It is associated with serious hazards and side effects, such as hemolytic anemia and methemoglobinemia. However, there is no report of primaquine causing liver injury in Korea. We describe a case of acute liver failure following primaquine overdose in a 19-year-old man.

Keyword

Primaquine; Drug-induced liver injury; Liver failure, Acute

MeSH Terms

Anemia, Hemolytic
Drug-Induced Liver Injury
Humans
Korea
Liver
Liver Failure, Acute*
Malaria
Methemoglobinemia
Plasmodium vivax
Primaquine
Schizonts
United States Food and Drug Administration
Young Adult
Primaquine
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr